On April 28, 2006 Chen Yuan-tsong, director of the Institute of Biomedical Sciences at Academia Sinica, finally saw his efforts of 15 years bear fruit. Myozyme, a drug he had developed for treating Pompe disease, was simultaneously approved for sale by the US Food and Drug Administration and the European Medicines Agency.
4 月 28 日，中研院生醫所所長陳垣崇持續 15 年的努力終於開花結果──他所研發的「龐貝氏症」解藥 Myozyme，同步獲得美國藥物食品管理局及歐盟醫藥品管理局核准上市。